| [1] | Jiang R., Zhao S., Wang R., et al. (2018). Safety and efficacy of Atorvastatin for Chronic Subdural Hematoma in Chinese patients: A randomized clinical trial. JAMA neurol. 75:1338−1346. DOI:10.1001/jamaneurol.2018.2030 |
| [2] | Miah I. P., Holl D. C., Blaauw J., et al. (2023). Dexamethasone versus surgery for Chronic Subdural Hematoma. N. Engl. J. Med. 388:2230−2240. DOI:10.1056/NEJMoa2216767 |
| [3] | Fiorella D., Monteith S. J., Hanel R., et al. (2024). Embolization of the middle meningeal artery for Chronic Subdural Hematoma. N. Engl. J. Med. 392:855−864. DOI:10.1056/NEJMoa2409845 |
| [4] | Liu J., Ni W., Zuo Q., et al. (2024). Middle meningeal artery embolization for Nonacute Subdural Hematoma. N. Engl. J. Med. 391:1901−1912. DOI:10.1056/NEJMoa2401201 |
| [5] | Davies J. M., Knopman J., Mokin M., et al. (2024). Adjunctive middle meningeal artery embolization for Subdural Hematoma. N. Engl. J. Med. 391:1890−1900. DOI:10.1056/NEJMoa2313472 |
| Lv Y., Gao G. and Liu B. (2025). Exploring the treatment of Chronic Subdural Hematoma: Crossing the river by feeling the stones. The Innovation Medicine 3:100122. https://doi.org/10.59717/j.xinn-med.2025.100122 |
To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com.
Exploring the treatment of Chronic Subdural Hematoma: Crossing the river by feeling the stones